参考文献/References:
[1]员许民.血浆血管内皮生长因子与2型糖尿病微血管病变的关系研究[J].现代中西医结合杂志,2011,20(34):4327-4328.
[2]王庆国,丁静,权翠侠.同型半胱氨酸在糖尿病视网膜病变诊断中的应用[J].临床荟萃,2011,26(2):108-109.
[3]Zhang D,Chen Y,Xie X,et al.Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells[J].J Mol Cell Cardiol,2012,53(4):487-496.
[4]汤建雷,袁莉,刘贤称.胱抑素C对2 型糖尿病肾病的诊断价值[J].南通大学学报(医学版),2012,32(4):272-273.
[5]刘文花,刘海霞,胡文博.糖尿病肾病患者血清胱抑素C、β2微球蛋白水平及其与eGFR的相关性[J].中国老年学杂志,2015,35(11):3002-3003.
[6]陈璐,王龙,华飞,等.2型糖尿病患者血清胱抑素C与视网膜病变的关系[J].临床荟萃,2015,30(7):796-798.
[7]刘宋芳,王述进,左红,等.2型糖尿病患者同型半胱氨酸与大血管病变的关系[J].中国循环杂志,2015,30(2):130-132.
[8]Go Y,Jones DP.Cysteine cystine redox signaling in cardiovascular disease[J].Free Radical Biology and Medicine,2011,50(4):495-509.
[9]Yeung BH,Wong KY,Lin MC,et al.Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2[J].Br J Cancer,2008,99(2):283-293.
[10]赖静怡,张颖栩,黄焕葵.血清胱抑素C及血脂水平与糖尿病视网膜病变的关系研究[J].国际眼科杂志,2015,15(11):2003-2005.
[11]董鹏,王玉环,荆爱玉,等.2型糖尿病视网膜病变与肾脏早期损伤指标的关系[J].安徽医药,2015,19(1):127-129.
[12]胡丽,皮银珍,刘罗坤.血清胱抑素C及β2微球蛋白对2型糖尿病视网膜病变预测价值研究[J].现代诊断与治疗,2016,27(13):2463-2464.
[13]Karabag T,Kaya A,Temizhan A,et al.The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease[J].Acta Diabetol,2007,44(2):69-75.
[14]Jindal A,Garcia-Touza M,Jindal N,et al.Diabetic kidney disease and the cardiorenal syndrome:old disease,new perspectives[J].Endocrinol Metab Clin North Am,2013,42(4):789-808.
相似文献/References:
[1]郭 明,郑继伟,马丽平.25(OH)D3与糖尿病视网膜病变的关系研究[J].医学信息,2018,31(08):99.[doi:10.3969/j.issn.1006-1959.2018.08.031]
GUO Ming,ZHENG Ji-wei,MA Li-ping.Study on the Relationship between 25(OH)D3 and Diabetic Retinopathy[J].Journal of Medical Information,2018,31(17):99.[doi:10.3969/j.issn.1006-1959.2018.08.031]
[2]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(17):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[3]罗妮娜,金昌德,陈文莉.中西医结合护理在老年糖尿病视网膜病变低视力患者中应用及效果观察[J].医学信息,2018,31(19):165.[doi:10.3969/j.issn.1006-1959.2018.19.052]
LUO Ni-na,JIN Chang-de,CHEN Wen-li.Application and Effect of Integrated Traditional Chinese and Western Medicine Nursing in Elderly Patients with Diabetic Retinopathy with Low Visual[J].Journal of Medical Information,2018,31(17):165.[doi:10.3969/j.issn.1006-1959.2018.19.052]
[4]郑莹莹.血清胱抑素C、尿β2微球蛋白联合检测在糖尿病肾损害早期诊断中的价值[J].医学信息,2019,32(01):170.[doi:10.3969/j.issn.1006-1959.2019.01.054]
ZHENG Ying-ying.The Value of Combined Detection of Serum Cystatin C and Urinary β2 Microglobulin in the Early Diagnosis of Diabetic Renal Damage[J].Journal of Medical Information,2019,32(17):170.[doi:10.3969/j.issn.1006-1959.2019.01.054]
[5]张 健,徐丹丹,王伟涛.胱抑素C、尿微量白蛋白/肌酐比值对早期糖尿病肾病的诊断价值[J].医学信息,2019,32(08):176.[doi:10.3969/j.issn.1006-1959.2019.08.056]
ZHANG Jian,XU Dan-dan,WANG Wei-tao.Diagnostic Value of Cystatin C and Urine Microalbumin/Creatinine Ratio for Early Diabetic Nephropathy[J].Journal of Medical Information,2019,32(17):176.[doi:10.3969/j.issn.1006-1959.2019.08.056]
[6]潘 浩.依帕司他片辅助治疗对糖尿病视网膜病变患者SOD、TAOC及TNF-α水平的影响[J].医学信息,2020,33(05):100.[doi:10.3969/j.issn.1006-1959.2020.05.030]
PAN Hao.Effects of Adjuvant Epalrestat on SOD,TAOC and TNF-α Levels in Patients with Diabetic Retinopathy[J].Journal of Medical Information,2020,33(17):100.[doi:10.3969/j.issn.1006-1959.2020.05.030]
[7]李 娟,冯双双,康京京,等.尿β2微球蛋白水平与2型糖尿病患者视网膜病变和肾脏病变的相关性[J].医学信息,2020,33(19):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
LI Juan,FENG Shuang-shuang,KANG Jing-jing,et al.Correlation Between Urine β2 Microglobulin Level and Retinopathy and Nephropathy in Type 2 Diabetic Patients[J].Journal of Medical Information,2020,33(17):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
[8]孙天慧,谭晓霞,连晓芬,等.2型糖尿病合并视网膜病变的影响因素分析[J].医学信息,2020,33(21):94.[doi:10.3969/j.issn.1006-1959.2020.21.027]
SUN Tian-hui,TAN Xiao-xia,LIAN Xiao-fen,et al.Analysis of Influencing Factors of Type 2 Diabetes with Retinopathy[J].Journal of Medical Information,2020,33(17):94.[doi:10.3969/j.issn.1006-1959.2020.21.027]
[9]张运涛,宋丽梅.钙神经蛋白抑制剂对糖尿病肾病的治疗效果及对肾脏炎症调节作用的影响[J].医学信息,2021,34(04):145.[doi:10.3969/j.issn.1006-1959.2021.04.039]
ZHANG Yun-tao,SONG Li-mei.The Therapeutic Effect of Calcineurin Inhibitor on Diabetic Nephropathy and Its Influence on the Regulation of Renal Inflammation[J].Journal of Medical Information,2021,34(17):145.[doi:10.3969/j.issn.1006-1959.2021.04.039]
[10]彭 越,高 宇,王云飞,等.VEGF在糖尿病视网膜病变发病机制中的作用[J].医学信息,2021,34(05):36.[doi:10.3969/j.issn.1006-1959.2021.05.011]
PENG Yue,GAO Yu,WANG Yun-fei,et al.The Role of VEGF in the Pathogenesis of Diabetic Retinopathy[J].Journal of Medical Information,2021,34(17):36.[doi:10.3969/j.issn.1006-1959.2021.05.011]